compound c

Compound C108 is an inhibitor of GTPase-activating protein SH3 domain-binding protein 2 (G3BP2). Compound C108 can be used in studies about breast tumors and esophageal squamous cell carcinoma.

MDH1/2 inhibitor compound 16c is a useful organic compound for research related to life sciences and the catalog number is T64662.

Compound CC50616, with CAS No. 884507-31-7, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound CC50616 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Clopidogrel Related Compound C is an isomer of Clopidogrel. Clopidogrel is a P2Y12 receptor antagonist that reduces platelet aggregation, used to prevent thrombotic events in coronary artery disease, peripheral artery disease, and cerebrovascular disease.

Compound CSC000682698 is a high-purity biochemical reagent with CAS number 123530-67-6, suitable for biochemical experiments and drug synthesis research.

Compound CSC000750700 is a high-purity biochemical reagent with CAS number 23457-00-5, suitable for biochemical experiments and drug synthesis research.

Compound CSC000017688 is a high-purity biochemical reagent with CAS number 6497-88-7, suitable for biochemical experiments and drug synthesis research.

Compound CSC000754622 is a high-purity biochemical reagent with CAS number 102880-53-5, suitable for biochemical experiments and drug synthesis research.

Compound CSC000681006 is a high-purity biochemical reagent with CAS number 89152-61-4, suitable for biochemical experiments and drug synthesis research.

Dorsomorphin (BML-275) is an AMPK inhibitor (Ki=109 nM) that is selective and ATP-competitive. Dorsomorphin inhibits the BMP type I receptors ALK2, ALK3, and ALK6. Dorsomorphin induces autophagy, and possesses antitumor activity.

Dorsomorphin dihydrochloride (BML-275 2HCl) is a potent, selective and ATP-competitive AMPK inhibitor (Ki: 109 nM) and does not exhibit significant activity on structurally related kinases.

Isoxepac (Olopatadine USP Related Compound C) is a non-steroidal anti-antiphlogistic agent and analgesic.

hCAII-IN-8 is a highly selective inhibitor of carbonic anhydrase (CA) with an IC50 value of 0.18 μM for hCA II.

Valsartan benzyl ester is a intermediate of Valsartan.

Glycerophosphoric acid is one of the main components of teichoic acid in bacterial cell walls and is a common emulsifier.

PF-4522654 is a potent and selective 5-HT2C receptor agonist.

TFEB activator 1 (Curcumin analog compound C1) is an activator of transcription factor EB (TFEB) with promise for the prevention or treatment of Alzheimer's disease.

NVS-PAK1-1 is a potent allosteric inhibitor of PAK1 with an IC 50 of 5 nM for dephosphorylated PAK1 and 6 nM for phosphorylated PAK1 as assessed. Inhibition is ATP-competitive, most likely due to indirect competition due to incompatibility of ATP binding with the DFG-out binding conformation of the allosteric compound. NVS-PAK1-1 has an IC50 of 270 nM against dephosphorylated PAK2 and 720 nM against phosphorylated PAK2 respectively [1].

c-Fms-IN-13 (compound 14) is a potent FMS kinase inhibitor (IC50 = 17 nM) and serves as an anti-inflammatory agent.

[1]Benzothiopyrano[4,3-c]pyrazole-3-carboxamide, n-[3-(4-cyclohexyl-1-piperazinyl)propyl]-1,4-dihydro-1-methyl- is a useful organic compound for research related to life sciences.

C-AFG is a useful organic compound for research related to life sciences. The catalog number is T67794 and the CAS number is 110312-78-2.

C-BVDU is a very potent and selective anti-herpes-virus compound.

GR-95168 ((+)-C-BVDU) is an antiviral compound for the study of herpes simplex virus infections type 1 and type 2.

Elgodipine significantly reduced the incidence and severity of exercise-induced angina pectoris systemically and was able to inhibit vascular smooth muscle proliferation through a mechanism independent of the expression of the transcription factors c-fos and c-jun. The Elgodipine-induced inhibition was voltage-dependent. Elgodipine is a potential compound for the treatment of angina pectoris.